|
Peregrine Pharmaceuticals Inc News is an EIN News Service for health professionals. Constantly updated news and information about health.
Latest Peregrine Pharmaceuticals Inc News
- Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholip 4 Nov 2009 19:50 GMT
... Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral ... viral genomic mutations that lead to anti-viral drug resistance. Bavituximab, which is Peregrine's most advanced ...
- Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies 4 Nov 2009 19:31 GMT
... Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral ... viral genomic mutations that lead to anti-viral drug resistance. Bavituximab, which is Peregrine's most advanced ...
- Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibod 4 Nov 2009 19:32 GMT
... TUSTIN, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that the ... viral genomic mutations that lead to anti-viral drug resistance. Bavituximab, which is Peregrine's most advanced ...
- USPTO awards Peregrine Pharmaceuticals patent for anti-viral uses of phosphatidylserine targeting antibodies 5 Nov 2009 06:14 GMT
... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that the ... viral genomic mutations that lead to anti-viral drug resistance. Bavituximab, which is Peregrine's most advanced ...
- Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements 3 Nov 2009 20:30 GMT
... TUSTIN, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that on November 3, 2009, the Company received notice ...
- Peregrine Awarded Second Broad US Patent 5 Nov 2009 08:50 GMT
... TUSTIN, CA - Peregrine Pharmaceuticals Inc. announced that the US Patent and ... in the December 2008 edition of Nature Medicine showing that bavituximab and other PS-targeting antibodies ...
- Peregrine Receives US Patent For Phospholipid-Targeting Antibodies 5 Nov 2009 07:34 GMT
... Peregrine Receives US Patent For Phospholipid-Targeting Antibodies The ... the treatment of all viral infections Peregrine Pharmaceuticals has received US Patent Number 7,611,704, which ... viral genomic mutations that lead to anti-viral drug resistance. Steven King, president and CEO of ...
- Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies (PRN) 4 Nov 2009 19:30 GMT
... Steven W. King, president and CEO of Peregrine. "We are especially pleased at the scope ... our ongoing research funded by a Transformational Medical Technologies Initiative contract to study the potential ... viral genomic mutations that lead to anti-viral drug resistance. Bavituximab, which is Peregrine's most advanced ...
- Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements (PRN) 3 Nov 2009 20:30 GMT
... is a biopharmaceutical company with a portfolio of innovative monoclonal ... its lead product candidates bavituximab and Cotara®. Peregrine also has in-house manufacturing capabilities through its ...
- Affitech Announces New Scientific Findings for its r84 Fully Human VEGF/VEGFR2 Selective Antibody 6 Nov 2009 12:52 GMT
... immune suppression.â?? Strategic Focus on Cell Surface Drug Targets Affitech's business strategy now focuses on ... rights to r84/AT001, previously in development at Peregrine Pharmaceuticals Inc., (Nasdaq: PPHMD) (Peregrine) were secured in ...
- InterMune seeks FDA marketing approval for pirfenidone 5 Nov 2009 06:42 GMT
... today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Trac... InterMune, ... MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has begun to... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that ...
- Once-Daily HCV Protease Inhibitors Show Early Promise 3 Nov 2009 22:11 GMT
... website or blog: BOSTON -- Two investigational drugs targeting the hepatitis C virus (HCV) protease ... Novartis, Wyeth, GlobeImmune, Zymogenetics, Ocera, Intercept, Conatus, Pharmasset, and Pfizer. Sulkowski reported relationships with Boehringer ... Gilead, Vertex, Tibotec, Bristol-Myers Squibb, Pfizer, Medarex, Peregrine, Debiopharm, and Abbott. Several co-authors were employees ...
- India Faces Health Threats As Vultures Vanish [opinion] 2 Nov 2009 08:30 GMT
... Dr Munir Virani, programme director for The Peregrine Fund for Africa and South Asia with ... The chemical diclofenac is a non-steroid anti-inflammatory drug used as a painkiller for cattle. Despite ... site tends to birds in need of medical attention. In 2005, a honey buzzard tried ...
- Peregrine, eight other companies take top honors in local high-tech awards 31 Oct 2009 09:31 GMT
... something amiss? Let us know at sosdnews@uniontrib.com Peregrine, eight other companies take top honors in ... satellite modems, won for communications products. The medical technologies category was won by OneRecovery, which ...
- Man, 22, killed by cocaine poisoning 30 Oct 2009 19:57 GMT
... was in the habit of taking the drug recreationally. But Coroner Roger Whittaker warned that ... of drugs, Coroner Roger Whittaker said the medical cause of Mr Rehman’s death had been ... window from his flat in Westwood Hall, Peregrine Way, Bradford, on two occasions, including on ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
| |
Healthcare Industry Today
|